ZA889711B - A process for the preparation of antibodies by genetic engineering - Google Patents

A process for the preparation of antibodies by genetic engineering

Info

Publication number
ZA889711B
ZA889711B ZA889711A ZA889711A ZA889711B ZA 889711 B ZA889711 B ZA 889711B ZA 889711 A ZA889711 A ZA 889711A ZA 889711 A ZA889711 A ZA 889711A ZA 889711 B ZA889711 B ZA 889711B
Authority
ZA
South Africa
Prior art keywords
antibodies
preparation
genetic engineering
hapten
antigen
Prior art date
Application number
ZA889711A
Other languages
English (en)
Inventor
Andreas Plueckthun
Plueckthun Andreas
Arne Skerra
Skerra Arne
Original Assignee
Plueckthun Andreas
Skerra Arne
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=6343878&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ZA889711(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Plueckthun Andreas, Skerra Arne filed Critical Plueckthun Andreas
Publication of ZA889711B publication Critical patent/ZA889711B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/62—DNA sequences coding for fusion proteins
    • C12N15/625—DNA sequences coding for fusion proteins containing a sequence coding for a signal sequence
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/62—DNA sequences coding for fusion proteins
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/02—Fusion polypeptide containing a localisation/targetting motif containing a signal sequence
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/035—Fusion polypeptide containing a localisation/targetting motif containing a signal for targeting to the external surface of a cell, e.g. to the outer membrane of Gram negative bacteria, GPI- anchored eukaryote proteins

Landscapes

  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Microbiology (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Saccharide Compounds (AREA)
  • Steroid Compounds (AREA)
ZA889711A 1987-12-31 1988-12-29 A process for the preparation of antibodies by genetic engineering ZA889711B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19873744595 DE3744595A1 (de) 1987-12-31 1987-12-31 Verfahren zur gentechnischen herstellung von antikoerpern

Publications (1)

Publication Number Publication Date
ZA889711B true ZA889711B (en) 1989-09-27

Family

ID=6343878

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA889711A ZA889711B (en) 1987-12-31 1988-12-29 A process for the preparation of antibodies by genetic engineering

Country Status (12)

Country Link
EP (1) EP0324162B1 (da)
JP (1) JP2771204B2 (da)
KR (1) KR970007861B1 (da)
AT (1) ATE102651T1 (da)
AU (1) AU628310B2 (da)
DE (2) DE3744595A1 (da)
DK (1) DK732988A (da)
ES (1) ES2063022T3 (da)
HU (1) HU212592B (da)
IE (1) IE62257B1 (da)
PT (1) PT89362B (da)
ZA (1) ZA889711B (da)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4816567A (en) 1983-04-08 1989-03-28 Genentech, Inc. Recombinant immunoglobin preparations
US5576195A (en) * 1985-11-01 1996-11-19 Xoma Corporation Vectors with pectate lyase signal sequence
US5618920A (en) * 1985-11-01 1997-04-08 Xoma Corporation Modular assembly of antibody genes, antibodies prepared thereby and use
US6916605B1 (en) 1990-07-10 2005-07-12 Medical Research Council Methods for producing members of specific binding pairs
US7063943B1 (en) 1990-07-10 2006-06-20 Cambridge Antibody Technology Methods for producing members of specific binding pairs
US6172197B1 (en) 1991-07-10 2001-01-09 Medical Research Council Methods for producing members of specific binding pairs
GB9015198D0 (en) * 1990-07-10 1990-08-29 Brien Caroline J O Binding substance
GB9206318D0 (en) * 1992-03-24 1992-05-06 Cambridge Antibody Tech Binding substances
SE9101433D0 (sv) * 1991-05-13 1991-05-13 Marianne Hansson Recombinant dna sequence and its use
US6492160B1 (en) 1991-05-15 2002-12-10 Cambridge Antibody Technology Limited Methods for producing members of specific binding pairs
US5871907A (en) * 1991-05-15 1999-02-16 Medical Research Council Methods for producing members of specific binding pairs
US5962255A (en) * 1992-03-24 1999-10-05 Cambridge Antibody Technology Limited Methods for producing recombinant vectors
US6225447B1 (en) 1991-05-15 2001-05-01 Cambridge Antibody Technology Ltd. Methods for producing members of specific binding pairs
US5858657A (en) * 1992-05-15 1999-01-12 Medical Research Council Methods for producing members of specific binding pairs
US7018809B1 (en) 1991-09-19 2006-03-28 Genentech, Inc. Expression of functional antibody fragments
US6146850A (en) * 1991-11-04 2000-11-14 Xoma Corporation Proteins encoding gelonin sequences
US5837491A (en) * 1991-11-04 1998-11-17 Xoma Corporation Polynucleotides encoding gelonin sequences
US5621083A (en) 1991-11-04 1997-04-15 Xoma Corporation Immunotoxins comprising ribosome-inactivating proteins
ES2313867T3 (es) 1991-12-02 2009-03-16 Medical Research Council Produccion de anticuerpos anti-auto de repertorios de segmentos de anticuerpo expresados en la superficie de fagos.
WO1993012246A1 (en) * 1991-12-18 1993-06-24 The University Of Calgary Expression-secretion vectors for the production of biologically active fv fragments
US5733743A (en) * 1992-03-24 1998-03-31 Cambridge Antibody Technology Limited Methods for producing members of specific binding pairs
US7368111B2 (en) 1995-10-06 2008-05-06 Cambridge Antibody Technology Limited Human antibodies specific for TGFβ2
GB9705376D0 (en) * 1997-03-14 1997-04-30 Harris William J Antibody fragment formulations and assay formats for detecting the presence an d concentration of analytes
US6492497B1 (en) 1999-04-30 2002-12-10 Cambridge Antibody Technology Limited Specific binding members for TGFbeta1
MXPA04001566A (es) * 2001-08-27 2004-05-17 Genentech Inc Un sistema para expresion y ensamblado de anticuerpos.
EP1908769A1 (en) * 2001-08-27 2008-04-09 Genentech, Inc. A system for antibody expression and assembly
EP2102354B1 (en) * 2007-01-12 2017-08-16 Dow Global Technologies LLC Apparatus and methods for osmotically shocking cells
US10262788B2 (en) 2013-12-12 2019-04-16 Koninklijke Philips N.V. Method to enable standard alternating current (AC)/direct current (DC) power adapters to operate in high magnetic fields

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8308235D0 (en) * 1983-03-25 1983-05-05 Celltech Ltd Polypeptides
EP0196864A3 (en) * 1985-03-25 1988-03-23 Cetus Corporation Alkaline phosphatase-mediated processing and secretion of recombinant proteins, dna sequences for use therein and cells transformed using such sequences
JPS62201581A (ja) * 1986-02-28 1987-09-05 Rikagaku Kenkyusho 新規プラスミド、微生物細胞及びヒト免疫グロブリンＧ　Ｆｃ領域蛋白質の製造方法
EP0234592A1 (en) * 1986-02-28 1987-09-02 Teijin Limited Plasmid containing DNA fragment coding for human immunoglobulin G Fc region protein and use thereof for production of said protein
AU2263288A (en) * 1987-07-16 1989-02-13 Codon Transfected cells containing plasmids having genes oriented in opposing directions and methods of obtaining the same
CA1341235C (en) * 1987-07-24 2001-05-22 Randy R. Robinson Modular assembly of antibody genes, antibodies prepared thereby and use

Also Published As

Publication number Publication date
DK732988D0 (da) 1988-12-30
JPH02799A (ja) 1990-01-05
IE883893L (en) 1989-06-30
ES2063022T3 (es) 1995-01-01
IE62257B1 (en) 1995-01-11
DK732988A (da) 1989-07-01
KR890010203A (ko) 1989-08-07
HU212592B (en) 1996-08-29
AU2761788A (en) 1989-07-06
AU628310B2 (en) 1992-09-17
EP0324162A1 (de) 1989-07-19
ATE102651T1 (de) 1994-03-15
JP2771204B2 (ja) 1998-07-02
PT89362B (pt) 1993-08-31
DE3744595A1 (de) 1989-07-13
KR970007861B1 (ko) 1997-05-17
DE3888337D1 (de) 1994-04-14
EP0324162B1 (de) 1994-03-09
PT89362A (pt) 1989-12-29
HUT49169A (en) 1989-08-28

Similar Documents

Publication Publication Date Title
ZA889711B (en) A process for the preparation of antibodies by genetic engineering
Russell Wall-associated protein antigens of Streptococcus mutans
US4948874A (en) Purified protein G from streptococcal bacteria
IL87255A (en) Dna constructs containing a kluyveromycesalpha- factorleader sequence for directingsecretion of heterologouspolypeptides
WO1998027114A3 (en) Mammalian cell surface antigens; related reagents
AU4055697A (en) Mammalian cell surface antigens; related reagents
EP0325045A3 (en) Immunoassay method for detecting antigens
EP0352761A3 (de) Antigenkonstrukte von "Major Histocompatibility Complex" Klasse I Antigenen mit spezifischen Trägermolekülen, ihre Herstellung und Verwendung
KR19990044528A (ko) 세포 표면에 세포성분의 부착 및 표현과 관련된 물질 및 방법
ATE44768T1 (de) Verfahren zur mikrobiologischen herstellung von menschlichem serum-albumin.
Dübel et al. Regulated secretion and purification of recombinant antibodies in E. coli
WO1997021812A3 (en) Mammalian chemokine ccf8 and chemokine receptor cckr3
WO1998025958A3 (en) Mammalian cell surface antigens comprising structural motifs characteristic of a member of the TNF ligand family
WO1998024906A3 (en) Isolated mammalian monocyte cell genes; related reagents
WO1998011226A3 (en) Mammalian chemokines, related reagents
JPH07504090A (ja) 触媒性部分の発現および触媒性部分の濃縮に係わる反応−ベース選別
WO1992007939A3 (en) Polypeptide with 46kd hmfg differentiation antigen binding specificity
MX9603266A (es) Genes de timocina de mamiferos.
EP0276984A3 (en) Measuring anti-dna antibodies
Wu et al. Artificial antibodies for affinity chromatography of homologous proteins: application to blood clotting proteins
SE8802939D0 (sv) A method for the production and isolation of a fusion protein in eukaryotic cells
EP0335567A3 (en) Controlled release of periplasmic proteins into the medium
Grange et al. Serum angiotensin-converting enzyme and delayed hypersensitivity in pulmonary tuberculosis
Shimizu et al. Techniques for assaying C 1, C 2 and D botulinal antitoxins.
MX9703956A (es) Genes purificados que codifican antigenos de superficie de celulas de mamiferos; proteinas y anticuerpos.